Robocath, a company that designs, develops and commercialises cardiovascular robotic systems for the treatment of vascular diseases, has successfully completed six robotic coronary angioplasties with R-One, in a first for the continent of Africa.
The Percutaneous Coronary Interventions (PCI) were performed by Dr Faizel Lorgat, an interventional cardiologist at the Netcare Christiaan Barnard Memorial Hospital, Cape Town, as part of a distribution agreement with Vertice MedTechGroup.
These procedures will lead to the creation of a purpose-made register that will add to the company’s clinical database, whilst it continues with a parallel European study of 60 patients.
Having completed more than 1,500 robot-assisted electrophysiology procedures, Lorgat now plans to aid in the continuous improvement of R-One and subsequent generations of the device.
Lucien Goffart, CEO of Robocath, said: “Dr Faizel Lorgat is a recognised interventional cardiologist who shares our vision of the future of interventional medicine.
“He was one of the first robotic operators worldwide in the vascular sector and we are delighted today to share with the Netcare Christiaan Barnard Memorial Hospital team their satisfaction in completing this first for the continent of Africa.”
